Published in Nature on February 09, 1989
Receptor editing in self-reactive bone marrow B cells. J Exp Med (1993) 5.49
Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 4.16
B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol (2012) 3.69
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52
Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J Exp Med (2006) 3.16
The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol (2009) 2.80
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med (2003) 2.77
Impaired early B cell tolerance in patients with rheumatoid arthritis. J Exp Med (2005) 2.39
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34
Germinal centers without T cells. J Exp Med (2000) 2.25
Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest (2007) 2.18
Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J (1994) 2.16
Reduced life span of anergic self-reactive B cells in a double-transgenic model. J Exp Med (1994) 2.15
Tyrosine phosphorylation of components of the B-cell antigen receptors following receptor crosslinking. Proc Natl Acad Sci U S A (1991) 2.11
Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med (2003) 2.09
B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol (2007) 2.08
Antibody polyspecificity and neutralization of HIV-1: a hypothesis. Hum Antibodies (2005) 2.03
Receptor editing occurs frequently during normal B cell development. J Exp Med (1998) 2.01
Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia. Nature (2015) 1.96
A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A (1991) 1.96
The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med (1996) 1.96
Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med (2004) 1.94
A transgenic model of autoimmune hemolytic anemia. J Exp Med (1992) 1.87
Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest (2001) 1.85
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85
Siglecs and immune regulation. Annu Rev Immunol (2012) 1.81
bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med (1996) 1.79
Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc Natl Acad Sci U S A (1989) 1.75
Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med (1993) 1.73
Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol (2007) 1.69
Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med (2013) 1.68
B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J Exp Med (1996) 1.66
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med (1996) 1.58
Cryptic B cell response to renal transplantation. Am J Transplant (2013) 1.57
Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57
Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med (1994) 1.49
Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49
Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE. Eur J Immunol (2014) 1.49
A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc Natl Acad Sci U S A (2000) 1.42
Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J Exp Med (2004) 1.42
The activation and inactivation of mature CD4 T cells: a case for peripheral self-nonself discrimination. Scand J Immunol (2014) 1.41
Enforced Bcl-2 expression inhibits antigen-mediated clonal elimination of peripheral B cells in an antigen dose-dependent manner and promotes receptor editing in autoreactive, immature B cells. J Exp Med (1997) 1.41
Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med (2003) 1.38
MicroRNAs prevent the generation of autoreactive antibodies. Immunity (2010) 1.38
STIM1, PKC-δ and RasGRP set a threshold for proapoptotic Erk signaling during B cell development. Nat Immunol (2011) 1.37
Human autoantibody silencing by immunoglobulin light chains. J Exp Med (2004) 1.34
MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Exp Med (1999) 1.33
Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci U S A (1997) 1.33
Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J Exp Med (1992) 1.33
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
Sustained activation of Lyn tyrosine kinase in vivo leads to autoimmunity. J Exp Med (2002) 1.29
Anti-HIV B Cell lines as candidate vaccine biosensors. J Immunol (2012) 1.28
Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol (2012) 1.27
CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med (1997) 1.26
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc Natl Acad Sci U S A (1996) 1.24
Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med (1999) 1.23
The cytoplasmic domains of immunoglobulin (Ig) alpha and Ig beta can independently induce the precursor B cell transition and allelic exclusion. J Exp Med (1995) 1.23
BAC-mediated transgenic expression of fluorescent autophagic protein Beclin 1 reveals a role for Beclin 1 in lymphocyte development. Cell Death Differ (2008) 1.23
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J Virol (1998) 1.21
Molecular underpinning of B-cell anergy. Immunol Rev (2010) 1.20
Dynamics of suppressor T cells: in vivo veritas. J Exp Med (2003) 1.20
Induction of tolerance to an IgG autoantibody. Proc Natl Acad Sci U S A (1992) 1.19
Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J Exp Med (1995) 1.18
Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med (1997) 1.18
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help. J Exp Med (2006) 1.17
Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci U S A (1990) 1.17
The bcl-2 gene product inhibits clonal deletion of self-reactive B lymphocytes in the periphery but not in the bone marrow. J Exp Med (1993) 1.17
Gonadal steroids and humoral immunity. Nat Rev Endocrinol (2012) 1.17
Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med (2012) 1.15
Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity (2008) 1.14
Esterases and autoimmunity: the sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol (2009) 1.12
Igkappa allelic inclusion is a consequence of receptor editing. J Exp Med (2007) 1.11
Antigen-stimulated dissociation of BCR mIg from Ig-alpha/Ig-beta: implications for receptor desensitization. Immunity (1999) 1.10
Receptor editing in self-reactive bone marrow B cells. The Journal of Experimental Medicine. 1993. 177: 1009-1020. J Immunol (2011) 1.10
Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J Immunol (2013) 1.10
Requirement for Rictor in homeostasis and function of mature B lymphoid cells. Blood (2013) 1.09
Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J Exp Med (1998) 1.09
Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice. J Exp Med (1999) 1.07
Cross-linking of membrane immunoglobulin D, in the absence of T cell help, kills mature B cells in vivo. J Exp Med (1995) 1.07
Editing anti-DNA B cells by Vlambdax. J Exp Med (2004) 1.06
B cells and autoimmunity. Curr Opin Immunol (2011) 1.06
Expression of recombinant antibodies. Front Immunol (2013) 1.06
Induction of tolerance in arthritogenic B cells with receptors of differing affinity for self-antigen. Proc Natl Acad Sci U S A (2006) 1.05
B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J Immunol (2004) 1.05
Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus. J Clin Invest (1996) 1.05
Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation. J Exp Med (2010) 1.05
A B cell superantigen-induced persistent "Hole" in the B-1 repertoire. J Exp Med (2000) 1.05
S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. Eur J Immunol (2010) 1.04
Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med (1997) 1.04
B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection. Proc Natl Acad Sci U S A (2000) 1.04
B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system. Eur J Immunol (2000) 1.03
Arginine methylation of the B cell antigen receptor promotes differentiation. J Exp Med (2010) 1.02
Light chain usage in anti-double-stranded DNA B cell subsets: role in cell fate determination. J Exp Med (1997) 1.02
A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J (1994) 1.02
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (1994) 11.22
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (1989) 7.52
Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science (1994) 7.34
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature (1990) 5.41
The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev (1998) 3.42
The influence of antigen organization on B cell responsiveness. Science (1993) 3.32
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol (1996) 2.96
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Peripheral deletion of self-reactive B cells. Nature (1991) 2.34
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res (1996) 2.23
Formation of cytoskeletal elements during mouse embryogenesis. Intermediate filaments of the cytokeratin type and desmosomes in preimplantation embryos. Differentiation (1980) 2.17
CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur J Immunol (1994) 2.00
Adverse effects of tribromoethanol as used in the production of transgenic mice. Lab Anim (1998) 1.94
T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J (1989) 1.94
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77
Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp Cell Res (1991) 1.70
Distinct sequence of negative or positive selection implied by thymocyte T-cell receptor densities. Nature (1990) 1.61
Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition. Eur J Immunol (1991) 1.47
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma. Ann Oncol (1996) 1.43
Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat Genet (1996) 1.18
Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol Aging (1996) 1.12
Nucleolar distribution of proteins B23 and nucleolin in mouse preimplantation embryos as visualized by immunoelectron microscopy. Development (1990) 1.09
T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease. Immunol Rev (1991) 1.08
Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev (1995) 1.07
Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol (1995) 1.02
The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells. J Exp Med (1998) 0.98
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol (2000) 0.97
Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Biotechnology (N Y) (1990) 0.97
Mta, a maternally inherited cell surface antigen of the mouse, is transmitted in the egg. Proc Natl Acad Sci U S A (1982) 0.97
Comparison of mouse and human HOX-4 complexes defines conserved sequences involved in the regulation of Hox-4.4. EMBO J (1992) 0.93
Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell Immunol (1994) 0.92
High-level expression of a human immunoglobulin gamma 1 transgene depends on switch region sequences. Eur J Immunol (1992) 0.92
Expression of human GLUT4 in mice results in increased insulin action. Diabetologia (1994) 0.92
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res (1992) 0.89
Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy. J Immunol (1998) 0.89
Expression of TEM-induced damage to postmeiotic stages of spermatogenesis of the mouse during early embryogenesis. II. Cytological investigations. Mutat Res (1978) 0.89
Identification and characterization of a human CD4 silencer. Eur J Immunol (1996) 0.88
IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. Int Immunol (1994) 0.88
T cell receptor (TcR) beta chain transgenic mice: studies on allelic exclusion and on the TcR+ gamma/delta population. Eur J Immunol (1990) 0.87
Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice. Transplantation (1998) 0.86
Molecular dissection of the paired helical filament. Neurobiol Aging (1995) 0.86
Visualization of Transcription in early mouse embryos. Chromosoma (1979) 0.86
Early differential effects of 3-methylcholanthrene and its "K-region" epoxide on mouse skin. Possible implication in the two-stage mechanism of tumorigenesis. J Natl Cancer Inst (1974) 0.86
The origin of chromosome aberrations in mature sperm of Drosophila: influence of sodium fluoride on treatments with trenimon and 1-phenyl-3,3-dimethyltriazene. Arch Genet (Zur) (1975) 0.85
Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells. J Immunol Methods (1999) 0.84
Safe biotechnology. Part 6. Safety assessment, in respect of human health, of microorganisms used in biotechnology. Appl Microbiol Biotechnol (1995) 0.81
Vaccination or tolerance to prevent diabetes. Eur J Immunol (1992) 0.81
Transplantation of the human insulin gene into fertilized mouse eggs. EMBO J (1982) 0.80
The expression of X-linked phosphoglycerate kinase in the early mouse embryo. Differentiation (1982) 0.80
Studies on liver regeneration. I. 131 Iododeoxyuridine as a precursor of DNA in normal and regenerating rat liver. Cell Tissue Kinet (1971) 0.80
Tau protein in Alzheimer's disease. Biochem Soc Trans (1995) 0.80
T helper cell unresponsiveness: rapid induction in antigen-transgenic and reversion in non-transgenic mice. Eur J Immunol (1994) 0.79
Effects of an epoxide hydrase inhibitor on in vivo binding of polycyclic hydrocarbons to DNA and on skin carcinogenesis. J Natl Cancer Inst (1974) 0.79
[Metabolism, proliferation and phagocytic activity of free cells in the peritoneal cavity of the mouse after injection of polystyrene particles]. Z Zellforsch Mikrosk Anat (1969) 0.79
Studies on liver regeneration. II. Effects of phenobarbital on the onset and pattern of rat liver regeneration following partial hepatectomy. Cell Tissue Kinet (1971) 0.79
Human tau transgenic mice. Towards an animal model for neuro- and glialfibrillary lesion formation. Adv Exp Med Biol (2001) 0.79
Thymus differentiation and T-cell specificity in nu/nu +/+ mouse aggregation chimaeras. EMBO J (1983) 0.79
Induction of aryl hydrocarbon hydroxylase in mouse tissues from a high and low cancer strain and their F 1 hybrids. J Natl Cancer Inst (1973) 0.78
Expression of aryl hydrocarbon hydroxylase induction in mouse tissues in vivo and in organ culture. Arch Biochem Biophys (1973) 0.77
Reutilization of thymidine in various groups of rat bone marrow cells. Blood (1971) 0.77
Ontogeny and selection of the T cell repertoire in transgenic mice. Semin Immunol (1989) 0.77
Expression of TEM-induced damage to postmeiotic stages of spermatogenesis of the mouse during early embryogenesis. I. Investigations with in vitro embryo culture. Mutat Res (1978) 0.77
Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement. Virchows Arch A Pathol Anat Histopathol (1992) 0.76
Recurrent cutaneous anaplastic large cell (CD30+) lymphoma associated with Epstein-Barr virus. A case report with 9-year follow-up. Am J Surg Pathol (1992) 0.76
[Cell migration and proliferation following subcutaneous injection of paraffin oil into mice]. Beitr Pathol Anat (1969) 0.76
[X-Irradiation of mature Drosophila sperm: mutation rates after insemination of aged and freshly produced eggs]. Arch Genet (Zur) (1974) 0.75
Simple vs. complex inheritance of inducible aryl hydrocarbon hydroxylase in mouse tissues. Biochem Genet (1975) 0.75
Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms. The Safety in Biotechnology Working Party of the European Federation of Biotechnology. Trends Biotechnol (1999) 0.75
ABLETOP, a well-tolerated, effective regimen for relapsing Hodgkin's disease. Swiss Group for Clinical Cancer Research (SAKK). Onkologie (1989) 0.75
A fine analysis of glucose-phosphate-isomerase patterns in single preimplantation mouse embryos. Differentiation (1985) 0.75
[Behavior of mouse spleen germinal center cells after secondary stimulation with tetanus toxoid injected into the footpads. Radiographic studies with thymidine-3H]. Virchows Arch B Cell Pathol (1969) 0.75
[Large cell anaplastic lymphomas in the immunocompromised host]. Verh Dtsch Ges Pathol (1991) 0.75
Protection of histones isolated from elastase-treated mouse epidermis. Anal Biochem (1974) 0.75
Effects of 3-methylcholanthrene and some related compounds upon the benzpyrene hydroxylase activity in fetal rat liver explants. Biochem Pharmacol (1971) 0.75
Maternal effects on x-ray-induced sex chromosome loss in mature sperm of Drosophila melanogaster: a storage effect in mature oocytes. Arch Genet (Zur) (1973) 0.75
Safe biotechnology. 8. Transport of infectious and biological materials. Working Party "Safety in Biotechnology" of the European Federation of Biotechnology. Appl Microbiol Biotechnol (1997) 0.75
Cellular responses to methylcholanthrene; the role of benzpyrene hydroxylase in the binding of polycyclic hydrocarbon to cytosol macromolecules in fetal rat liver explants. Arch Biochem Biophys (1972) 0.75
[Intestinal cytomegaly in childhood: electron microscopy studies of in-vivo collected material]. Zentralbl Allg Pathol (1972) 0.75
Experimental embryology of the mouse. Monogr Dev Biol (1986) 0.75
Transplantation of the human insulin gene into fertilized mouse eggs. Prog Clin Biol Res (1982) 0.75
[Determination of vitamin D activity in hypernephroma with hypercalcemic syndrome]. Helv Med Acta (1963) 0.75
Radioactively labeled iododeoxyuridine in the study of experimental liver regeneration. Curr Top Pathol (1975) 0.75
Interspecies crosses: aspects of animal protection. ALTEX (2009) 0.75
[Recent histologic and cytologic aspects of lung cancer]. Schweiz Rundsch Med Prax (1983) 0.75
The use of bacteriophages as indicators in host-mediated assays. Longevity of phages lambda, T4 and kappa in the blood-stream of mice. Mutat Res (1977) 0.75
Induction of benzpyrene-hydroxylase activity in fetal rat liver explants. I. Metabolism of 3-methylcholanthrene and differential effects of its derivatives on benzpyrene-hydroxylase activity. Biochim Biophys Acta (1972) 0.75
Malignant non-Hodgkin's lymphoma (NHL) in childhood. Retrospective analysis of 34 cases. Helv Paediatr Acta (1977) 0.75
Early morphologic alterations in mouse skin after topical application of 3-methylcholanthrene and its metabolites. J Natl Cancer Inst (1975) 0.75